Detalhe da pesquisa
1.
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Cell
; 173(7): 1770-1782.e14, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29906450
2.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061129
3.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516663
4.
Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.
Prostate
; 79(7): 701-708, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865311
5.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
N Engl J Med
; 375(5): 443-53, 2016 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27433846
6.
Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue.
Tumour Biol
; 37(9): 11861-11871, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055661
7.
Genetic variations at microRNA and processing genes and risk of oral cancer.
Tumour Biol
; 35(4): 3409-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297336
8.
Association between risk of oral precancer and genetic variations in microRNA and related processing genes.
J Biomed Sci
; 21: 48, 2014 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885463
9.
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.
NPJ Precis Oncol
; 8(1): 104, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760413
10.
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 26(1): 194-200, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564459
11.
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.
Cancer Res Commun
; 3(11): 2358-2374, 2023 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823778
12.
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.
Cancer Discov
; 13(3): 632-653, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399432
13.
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072760
14.
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES.
Res Sq
; 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196594
15.
Differential haplotype amplification leads to misgenotyping of heterozygote as homozygote when using single nucleotide mismatch primer.
Electrophoresis
; 33(23): 3564-73, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23161286
16.
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.
Nat Commun
; 13(1): 7475, 2022 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463275
17.
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA.
JAMA Oncol
; 2021 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34086042
18.
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.
Clin Cancer Res
; 27(3): 759-774, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199493
19.
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer.
JCI Insight
; 6(23)2021 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877933
20.
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
J Clin Invest
; 131(10)2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998604